Exchange: NASDAQ·Updated 07:57 PM EST

IMDX Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 16

Estimated EPS

-$0.24

Reported EPS

-$0.10

Surprise

+57.63%

Estimated Rev

$0.24M

Reported Rev

$0.56M

Surprise

+128.84%

Insight Molecular Diagnostics continues to target outgoing free cash flow of approximately $8M in Q4 2026; Q3 2026 free cash flow was approximately $7.3M, versus prior expectation of $8M.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.20
--
--
N/A
Q3 '26
-$0.24
-$0.10
57.63%
BEAT
Q2 '26
-$0.24
-$0.31
-29.17%
MISSED
Q1 '26
-$0.26
-$0.12
54.12%
BEAT
Q4 '25
-$0.24
-$0.72
-203.16%
MISSED

Advertisement|Remove ads.